tcr
specif
observ
zikv
patient
cell
present
termin
differenti
profil
express
granzym
b
maintain
abil
produc
find
provid
new
knowledg
immun
respons
profil
selflimit
infect
may
help
vaccin
efficaci
definit
identifi
possibl
immunopathogenet
mechan
sever
infect
zika
viru
zikv
emerg
arboviru
flavivirida
famili
isol
uganda
usual
caus
mild
selflimit
infect
nevertheless
sever
data
strongli
indic
high
rate
primari
microcephali
syndrom
zikv
infect
french
polynesia
brazil
current
licens
medic
intervent
drug
therapeut
vaccin
avail
treat
prevent
zikv
infect
develop
sever
diseas
wide
cross
reactiv
among
differ
flaviviru
risk
associ
antibodi
depend
enhanc
strongli
request
identif
protect
pathogenet
immun
signatur
zikv
zikv
infect
dendrit
cell
dc
antagon
type
interferon
respons
thu
subvert
dc
immunogen
acut
convalesc
phase
zikv
infect
increas
level
cytokin
report
suggest
polyfunct
tcell
respons
requir
recoveri
zikv
infect
nevertheless
unbalanc
immunoactiv
high
level
cerebrospin
fluid
associ
encephalomyel
although
main
role
play
humor
respons
involv
cell
respons
protect
zikv
infect
recent
suggest
mous
model
zikv
infect
moreov
activ
tcell
polar
also
recent
demonstr
mice
data
avail
cellularmedi
immun
respons
acut
phase
zikv
infect
human
aim
studi
studi
compar
phenotyp
function
tcell
patient
acut
zikv
dengu
viral
denv
infect
tcell
subset
healthi
donor
hd
zikv
denvinfect
patient
perform
multiparametr
flow
cytometri
fig
repres
panel
one
hd
one
zikvand
one
denvinfect
patient
shown
fig
tcell
frequenc
differ
three
group
kruskal
walli
kw
particular
compar
hd
signific
higher
tcell
frequenc
observ
zikvand
denvinfect
patient
fig
contrast
differ
tcell
frequenc
observ
among
group
fig
final
frequenc
tcell
popul
doubl
neg
dn
tcell
differ
three
group
kw
specif
signific
expans
dn
tcell
observ
zikv
infect
fig
impact
zikv
infect
tcell
activ
evalu
analyz
express
activ
marker
hladr
fig
b
fig
dn
fig
f
tcell
signific
differ
among
hd
zikv
denv
observ
activ
profil
kw
cell
kw
specif
compar
hd
higher
frequenc
po
po
hladr
po
tcell
observ
zikv
denv
patient
fig
moreov
signific
higher
frequenc
neg
hladr
po
tcell
observ
zikvpati
hd
fig
tcell
show
lower
level
activ
tcell
zikv
denv
patient
po
tcell
significantli
higher
zikv
denv
hd
fig
although
trend
increas
dn
cell
denv
infect
signific
differ
observ
activ
dn
tcell
among
hd
zikv
denv
probabl
due
small
sampl
size
fig
analysi
tcell
show
differ
differenti
profil
zikv
denv
hd
fig
contrast
signific
differ
observ
differenti
profil
kw
dn
kw
tcell
particular
zikv
patient
show
lower
frequenc
tcell
comparison
hd
denv
patient
parallel
higher
frequenc
tcell
tcell
zikv
respect
hd
fig
similar
result
obtain
analys
dn
tcell
inde
lower
frequenc
cmdn
tcell
observ
zikv
comparison
hd
denv
patient
parallel
higher
frequenc
temradn
tcell
zikv
respect
hd
fig
final
invers
correl
day
symptom
onset
em
tcell
frequenc
observ
pearson
r
r
squar
p
character
phenotyp
expand
dn
tcell
observ
zikv
infect
express
tcr
nk
marker
analys
flow
cytometri
result
show
larg
major
dn
tcell
express
tcr
fig
suggest
dn
tcell
popul
expand
zikv
infect
belong
tcell
subset
accordingli
frequenc
tcell
within
tcell
significantli
differ
among
hd
zikv
denv
kw
particular
tcell
significantli
higher
zikv
patient
hd
denv
patient
fig
notabl
tcell
expans
pronounc
patient
sampl
first
day
symptom
onset
rang
patient
sampl
day
rang
invers
correl
day
symptom
onset
tcell
frequenc
observ
pearson
r
r
squar
p
fig
although
reach
statist
signific
analysi
granzym
express
show
trend
increas
granzym
b
posit
tcell
zikv
patient
compar
hd
kw
fig
order
defin
function
properti
tcell
zikv
infect
test
abil
produc
cytokin
elispot
assay
fig
flow
cytometri
fig
e
mytogen
stimul
repres
cytometr
panel
shown
fig
shown
fig
signific
reduct
frequenc
produc
tcell
observ
zikv
patient
hd
zikv
median
pbmc
iqr
vs
hd
median
pbmc
iqr
p
analys
three
differ
cytokin
flow
cytometri
focus
found
elev
acut
zikv
patient
analysi
tcell
reveal
signific
differ
among
hd
zikv
denv
kw
particular
zikv
infect
associ
reduct
product
tcell
fig
note
tcell
maintain
abil
produc
well
hd
denv
fig
signific
differ
observ
produc
tcell
definit
immunolog
respons
zikv
infect
human
repres
key
issu
identifi
protect
profil
use
vaccin
develop
pathogenesi
studi
studi
first
report
dynam
tcell
profil
function
patient
acut
zikv
infect
import
find
studi
activ
tcell
cell
differenti
toward
effector
cell
substanti
expans
effector
tcell
first
day
symptom
onset
cytokin
modul
tcell
reduct
product
activ
tcell
extens
describ
sever
viral
infect
like
repres
effort
immun
system
counteract
viral
replic
nevertheless
excess
tcell
activ
observ
sever
viral
diseas
sever
denv
ebola
viral
ebov
infect
may
harm
host
increas
inflamm
promot
anergi
protect
tcell
found
zikv
infect
induc
signific
activ
tcell
confirm
recent
data
obtain
mice
frequenc
tcell
coexpress
hladr
similar
zikv
denv
patient
lower
ebov
infect
suggest
moder
activ
may
associ
protect
activ
mild
profil
diseas
acut
infect
denv
ebola
viru
activ
tcell
associ
increas
express
apoptot
marker
role
apoptosi
zikv
infect
remain
defin
abil
tcell
differenti
effector
key
featur
protect
respons
zikv
infect
tcell
differenti
toward
effector
describ
suggest
induct
well
coordin
immun
respons
particular
tcell
differenti
effector
memori
termin
differenti
cell
suggest
acquisit
cytokineproduc
cytotox
profil
studi
necessari
deepli
explor
function
properti
effector
tcell
effector
phenotyp
tcell
also
describ
mous
model
zikv
infect
nevertheless
although
express
effector
phenotyp
signific
reduct
produc
tcell
observ
respect
hd
denv
patient
specul
tcell
zika
infect
polar
produc
cytokin
chemokin
abil
zikv
inhibit
typei
ifn
product
respons
report
reduct
product
tcell
repres
new
find
whose
role
context
protectionpathogenesi
need
investig
differ
frequenc
tcell
observ
suggest
zikv
modifi
abil
tcell
produc
cytokin
inde
found
higher
sera
zikv
patient
current
studi
report
first
time
substanti
expans
tcell
zikv
infect
pronounc
first
day
symptom
onset
expand
tcell
present
effector
phenotyp
express
granzym
b
pillar
role
tcell
well
orchestr
immun
respons
viral
infect
well
document
inde
human
tcell
may
affect
progress
outcom
infecti
diseas
activ
tcell
abl
exert
direct
antivir
activ
perform
sever
stimulatori
activ
innat
adapt
immun
cell
sever
report
suggest
protect
role
tcell
acut
viral
infect
tcell
expand
quickli
respons
wnv
infect
produc
signific
amount
limit
viral
load
protect
host
lethal
enceph
could
directli
correl
tcell
expans
protect
effect
zikv
infect
sinc
patient
includ
studi
show
mild
clinic
cours
diseas
sequela
observ
direct
comparison
sever
mild
diseas
may
help
support
protect
role
tcell
zikv
infect
analysi
tcell
may
also
import
better
understand
pathogenesi
associ
sever
clinic
complic
zikv
infect
microcephali
foetus
andor
guillain
syndrom
adult
interestingli
expans
tcell
associ
recurr
abort
furthermor
profil
expand
tcell
might
contribut
placenta
damag
andor
inflamm
correl
foetal
brain
damag
zikv
infect
final
tcell
may
play
role
autoimmun
diseas
particular
guillain
syndrom
contribut
autoimmun
damag
tabl
serolog
virolog
data
report
tabl
elispot
assay
tcell
function
zika
acut
infect
assess
detect
interferongamma
product
use
enzymelink
immunosorb
spotform
cell
assay
elispot
pha
stimul
peripher
blood
mononuclear
cell
pbmc
thaw
cultur
medium
rpmi
fc
mmollit
lglutamin
assess
vital
trypan
blue
exclus
count
plate
cell
well
elispot
plate
aid
gmbh
strabberg
germani
pbmc
stimul
pha
includ
elispot
kit
hour
co
end
incub
elispot
assay
develop
accord
manufactur
instruct
spontan
cytokin
product
background
assess
incub
pbmc
clone
respect
becton
dickinson
mountain
view
ca
result
express
spot
form
cell
sfc
pbmc
stimul
cultur
subtract
spontan
background
